Vanguard Group’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$189M Buy
5,682,019
+77,428
+1% +$2.58M ﹤0.01% 1531
2025
Q1
$164M Sell
5,604,591
-26,730
-0.5% -$783K ﹤0.01% 1563
2024
Q4
$185M Buy
5,631,321
+85,339
+2% +$2.8M ﹤0.01% 1577
2024
Q3
$246M Buy
5,545,982
+49,245
+0.9% +$2.19M ﹤0.01% 1435
2024
Q2
$237M Sell
5,496,737
-75,284
-1% -$3.25M ﹤0.01% 1408
2024
Q1
$163M Buy
5,572,021
+44,583
+0.8% +$1.3M ﹤0.01% 1631
2023
Q4
$123M Buy
5,527,438
+59,851
+1% +$1.33M ﹤0.01% 1751
2023
Q3
$135M Sell
5,467,587
-52,000
-0.9% -$1.29M ﹤0.01% 1641
2023
Q2
$156M Buy
5,519,587
+95,660
+2% +$2.71M ﹤0.01% 1599
2023
Q1
$125M Buy
5,423,927
+88,851
+2% +$2.04M ﹤0.01% 1712
2022
Q4
$150M Buy
5,335,076
+109,979
+2% +$3.09M ﹤0.01% 1591
2022
Q3
$148M Buy
5,225,097
+21,396
+0.4% +$605K ﹤0.01% 1571
2022
Q2
$115M Buy
5,203,701
+117,887
+2% +$2.61M ﹤0.01% 1734
2022
Q1
$148M Buy
5,085,814
+17,224
+0.3% +$501K ﹤0.01% 1735
2021
Q4
$167M Sell
5,068,590
-377,231
-7% -$12.4M ﹤0.01% 1709
2021
Q3
$251M Sell
5,445,821
-144,585
-3% -$6.67M 0.01% 1459
2021
Q2
$308M Sell
5,590,406
-139,938
-2% -$7.71M 0.01% 1330
2021
Q1
$296M Buy
5,730,344
+104,631
+2% +$5.4M 0.01% 1318
2020
Q4
$244M Buy
5,625,713
+117,536
+2% +$5.09M 0.01% 1345
2020
Q3
$193M Sell
5,508,177
-236,733
-4% -$8.29M 0.01% 1307
2020
Q2
$307M Buy
5,744,910
+59,106
+1% +$3.16M 0.01% 1010
2020
Q1
$202M Buy
5,685,804
+78,949
+1% +$2.8M 0.01% 1125
2019
Q4
$268M Buy
5,606,855
+815,666
+17% +$38.9M 0.01% 1213
2019
Q3
$155M Buy
4,791,189
+152,420
+3% +$4.94M 0.01% 1488
2019
Q2
$231M Sell
4,638,769
-7,449
-0.2% -$372K 0.01% 1269
2019
Q1
$313M Buy
4,646,218
+24,269
+0.5% +$1.64M 0.01% 1051
2018
Q4
$213M Buy
4,621,949
+370,510
+9% +$17.1M 0.01% 1211
2018
Q3
$328M Buy
4,251,439
+109,849
+3% +$8.47M 0.01% 1053
2018
Q2
$349M Buy
4,141,590
+141,169
+4% +$11.9M 0.01% 989
2018
Q1
$327M Buy
4,000,421
+698,325
+21% +$57.1M 0.01% 977
2017
Q4
$189M Buy
3,302,096
+11,929
+0.4% +$682K 0.01% 1338
2017
Q3
$220M Buy
3,290,167
+75,397
+2% +$5.03M 0.01% 1211
2017
Q2
$165M Buy
3,214,770
+617,379
+24% +$31.8M 0.01% 1350
2017
Q1
$152M Buy
2,597,391
+129,159
+5% +$7.54M 0.01% 1414
2016
Q4
$103M Buy
2,468,232
+104,011
+4% +$4.34M 0.01% 1594
2016
Q3
$125M Buy
2,364,221
+258,630
+12% +$13.7M 0.01% 1433
2016
Q2
$88.2M Buy
2,105,591
+192,852
+10% +$8.08M 0.01% 1601
2016
Q1
$77.7M Buy
1,912,739
+48,726
+3% +$1.98M 0.01% 1638
2015
Q4
$121M Buy
1,864,013
+57,195
+3% +$3.71M 0.01% 1333
2015
Q3
$128M Buy
1,806,818
+185,256
+11% +$13.1M 0.01% 1275
2015
Q2
$180M Buy
1,621,562
+34,243
+2% +$3.81M 0.01% 1122
2015
Q1
$150M Buy
1,587,319
+295,617
+23% +$27.9M 0.01% 1213
2014
Q4
$145M Buy
1,291,702
+212,194
+20% +$23.8M 0.01% 1167
2014
Q3
$66.2M Buy
1,079,508
+220,819
+26% +$13.5M 0.01% 1641
2014
Q2
$39.3M Buy
858,689
+104,905
+14% +$4.81M ﹤0.01% 1946
2014
Q1
$29.5M Buy
753,784
+507,872
+207% +$19.9M ﹤0.01% 2052
2013
Q4
$5.89M Sell
245,912
-24,797
-9% -$594K ﹤0.01% 2708
2013
Q3
$7.57M Buy
+270,709
New +$7.57M ﹤0.01% 2528